Piper Sandler adjusted its stance on Amphastar Pharmaceuticals (NASDAQ:AMPH), downgrading the company's stock rating from Overweight to Neutral and significantly reducing the price target to $36.00 ...
In a report released today, Jason Gerberry from Bank of America Securities reiterated a Hold rating on Amphastar Pharmaceuticals (AMPH – ...
Check the time stamp on this data. Updated AI-Generated Signals for Amphastar Pharmaceuticals Inc. (AMPH) available here: ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Amphastar Pharmaceuticals Inc (Symbol: AMPH) entered into oversold territory, hitting an RSI ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at ...
Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, CA. This small manufacturing pharma concern is focused on making and distributing generic and proprietary injectable ...
Ever wonder which ETFs do the best job at beating the benchmark index? This list is a good place to start.
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at ...
Amphastar Pharmaceuticals, Inc. (AMPH) stock price is 36.37 and Amphastar Pharmaceuticals, Inc. (AMPH) 10-day simple moving average is 36.33. Amphastar Pharmaceuticals, Inc. (AMPH) stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback